[Evidence of compression therapy with special consideration of medical adaptive compression systems].

Evidenz der Kompressionstherapie unter besonderer Berücksichtigung der medizinischen adaptiven Kompressionssysteme.

Journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
ISSN: 1432-1173
Titre abrégé: Hautarzt
Pays: Germany
ID NLM: 0372755

Informations de publication

Date de publication:
Apr 2020
Historique:
pubmed: 27 2 2020
medline: 11 4 2020
entrez: 27 2 2020
Statut: ppublish

Résumé

For several decades, compression therapy, which is associated with few side effects, has been a basis for the conservative treatment of patients with phlebological and lymphological diseases. For the practical implementation of compression therapy, many different materials are available, some with system-specific advantages and disadvantages. Medical adaptive compression systems (MAK) are still a relatively new treatment option in Germany. Apart from the very good practical experience in clinical everyday life, the compilation of the scientific evidence of compression therapy also shows that the scientific data situation is significantly better than for many other medical areas, especially for the treatment of patients with venous diseases. It is important to note that compression therapy must reliably guarantee adequate compression pressure. If these conditions are met, it can be assumed on the basis of the currently available data that the clinical effectiveness of the different compression systems is comparably good. These aspects have now also been well tested for MAK, so that these analogies can be drawn. Therapists today can therefore choose between different, very effective therapy options and take individual factors, patient wishes and economic aspects into account when making their selection.

Identifiants

pubmed: 32100054
doi: 10.1007/s00105-020-04554-x
pii: 10.1007/s00105-020-04554-x
doi:

Types de publication

Journal Article Review

Langues

ger

Sous-ensembles de citation

IM

Pagination

301-308

Références

J Vasc Surg Venous Lymphat Disord. 2013 Jan;1(1):13-9
pubmed: 26993887
Lancet. 2014 Mar 8;383(9920):871-9
pubmed: 24315520
Z Evid Fortbild Qual Gesundhwes. 2009;103(6):391-400
pubmed: 19839216
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD002303
pubmed: 22895929
Cochrane Database Syst Rev. 2012 Nov 14;11:CD000265
pubmed: 23152202
Phlebology. 2018 Apr;33(3):163-184
pubmed: 28549402
Hautarzt. 2018 Mar;69(3):232-241
pubmed: 29184983
Cochrane Database Syst Rev. 2019 Sep 18;9:CD004177
pubmed: 31531971
Cochrane Database Syst Rev. 2014 May 12;(5):CD001899
pubmed: 24820100
Int Wound J. 2019 Aug;16(4):903-908
pubmed: 30900365
Hautarzt. 2016 Apr;67(4):311-23; quiz 324-5
pubmed: 26911976
Eur J Vasc Endovasc Surg. 2015 Sep;50(3):368-74
pubmed: 26160211
Dtsch Med Wochenschr. 2017 May;142(9):679-686
pubmed: 28454202
Phlebology. 2019 Apr;34(3):208-213
pubmed: 30099955
Cochrane Database Syst Rev. 2017 Sep 26;9:CD004174
pubmed: 28950030
J Vasc Surg Venous Lymphat Disord. 2019 Jan;7(1):17-28
pubmed: 30554745

Auteurs

Joachim Dissemond (J)

Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Essen, Hufelandstr. 55, 45122, Essen, Deutschland. joachim.dissemond@uk-essen.de.

Knut Kröger (K)

Klinik für Gefäßmedizin, Angiologie, HELIOS Klinikum Krefeld, Krefeld, Deutschland.

Markus Stücker (M)

Klinik für Dermatologie, Venerologie und Allergologie, Ruhr-Universität Bochum, Bochum, Deutschland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH